The “Rogue” Biologist Speaks His Mind
by Cliff Mintz Ph.D.
Synthetic biology is one of the hottest and most rapidly growing new fields in life sciences. While still largely ill-defined, synthetic biology is generally described as the application of the principles of molecular engineering to rationally and systematically construct unique molecules or forms of life with desired properties or characteristics.
Pulmatrix: A Blueprint For Obtaining Government Grants For Research
by James Netterwald, Ph.D.
Funding for scientific research nowadays is more competitive than ever. However, there are also more sources of funding now than ever before. The days of academic scientists receiving an NIH or NSF grant and then isolating themselves in their labs only to emerge with a scientific publication a few years later are over. For biotech and pharma companies, most of the funding for research used to come only from venture capitalists. Nowadays, it comes from both venture capitalists and from government grants.
When Your Science Leads To An Unexpected Business Opportunity
by Cliff Mintz Ph.D.
The MS market has historically been dominated by large biotech and pharma companies (e.g. Novartis, Biogen Idec, EMD Serono, Bayer Healthcare Pharmaceuticals, Teva). However, Acorda Therapeutics, a small public biotechnology company in Hawthorne, NY, is trying to change this trend. Early last year, the company received FDA approval of its first product, AMPYRA (dalfampridine), which is designed to improve walking in MS patients.
IT Strategies For The Lab
by Ulf Fuchslueger
Laboratory IT is a broad subject — covering research, development, and quality control. It also uses a wide range of different applications with varying scalability — from specialist single-platform solutions and instrument control software to companywide systems. The only thing they have in common is that they run on different platforms, are based on different
technologies, and are delivered and supported by different companies.
Geographic Eligibility: USA, Canada
About Life Science Leader Magazine :
Life Science Leader magazine is designed to not only inform readers of best practices that are occurring throughout the life cycle of the industry, but motivate them to implement those best practices in their own businesses. The editorial discusses issues that Life Science executives in the biopharm, traditional pharma, R&D, and contract manufacturing fields have in common, including business process management, information technology, regulatory compliance, and finance/business development.